COVID-19 vaccination: your questions answered

We answer your questions about the COVID-19 vaccination programme.

It is hugely encouraging to see the COVID-19 vaccination programme getting underway, but there can be no doubting the scale of the task ahead.

NHS staff have a critical role in its successful rollout, with vaccines starting to be administered in hospitals and by some PCNs. Unsurprisingly, the speed of events has prompted some MDU members to seek advice about their ethical and legal responsibilities.

Here we respond to some of the initial queries. However, with the situation changing quickly, some guidance is still awaited and we advise members to check relevant websites for the latest updates.

Who can prescribe and administer the vaccine?

The vaccine is a prescription only medicine. It will be administered under a new National Protocol issued by Public Health England and Public Health Wales and a Patient Group Direction has also been published.

The National Protocols enable more healthcare professionals and allied health staff to administer the COVID-19 vaccine as part of a mass programme by allowing the different stages of the vaccination process to be split into parts, i.e. clinical assessment and consent, preparation of the vaccine and administration of the vaccine.

The protocol explains that a clinical supervisor, who must be a registered doctor, nurse or pharmacist trained and competent in all aspects of the protocol, must be present and provide clinical supervision for the overall provision of clinical care provided under the legal authority of the protocol.

Further guidance is awaited in Northern Ireland and Scotland.

How should we prioritise patients?

The Joint Committee of Vaccination and Immunisation (JCVI) has set out a list of vaccine priority groups. Hospital hubs and practices are responsible for identifying patients for the priority cohort, starting with all those aged 80 years and over.

If demand is likely to exceed supply, you may need to consider patients by co-morbidities or take into account health inequalities. Where there are unfilled appointments, NHS England suggests residual supply is used to vaccinate staff who have been identified as being at high risk.

How should we obtain patient consent?

In FAQs about the vaccine, the GMC says doctors must be satisfied they have consent or other valid authority for vaccination, as is the case for any treatment. This includes 'speaking with patients to find out about allergies, their medical history and any contraindications.' The GMC says it expects there to be further guidance on how consent should be recorded across the four countries of the UK and whether to use a standard consent form.

The current NHS Standard operating procedure for primary care clarifies that all patients who are able to are required to give informed consent. It outlines that those being vaccinated should be able to understand, retain, and communicate:

  • the anticipated benefits of vaccination in the simplest of terms,
  • the likely side effects from vaccination and any individual risks they may run should be addressed, and
  • the disbenefits of not consenting to the vaccination.

In terms of documentation, it reminds us that there is no legal requirement for consent to be in writing and a signature on a consent form is not conclusive proof that consent has been given, but serves to record the decision and the discussions that have taken place. It further clarifies that consent should, however, be recorded and that the patient should be provided with written information about the vaccination.

Public Health England has also produced a range of patient information leaflets and consent forms (including for care home residents) although these should not be a substitute for talking to patients about any specific concerns.

What happens with patients who lack capacity to consent?

Where patients have been assessed as lacking capacity to make a decision, the GMC says you should determine whether there is someone with legal authority to consent to vaccination on their behalf.

If there is not, you will need to decide what option would be of overall benefit to them in consultation with other staff, those close to them and anything you know about their previously expressed views.

If you're responsible for delivering vaccination programmes in settings where a number of patients could lack capacity, make sure you allow enough time before a vaccination clinic to inform relatives and for any concerns to be discussed and documented.

In its letter to PCN designated sites, NHS England says it expects GP practices to highlight patients who may lack capacity when identifying patients for the initial vaccine cohort. Staff will then proceed according to its standard operating procedure.

The Scottish government has clarified that a section 47 certificate of incapacity must be completed by a doctor or other authorised healthcare professional in order to provide non-emergency treatment such as the COVID-19 vaccine to an adult who lacks capacity to give or refuse consent. 

What should we do to ensure patient safety?

Public Health England has published detailed guidance for healthcare practitioners on the vaccination programme and we expect the health services in other nations of the UK to do the same. The PHE guidance includes sections on the safe administration of the vaccine, contraindications and precautions.

Immunisation against infectious disease (the Green Book) includes a new chapter on the coronavirus vaccine covering contraindications, precautions and adverse events and the MHRA has published specific information for healthcare professionals about the Pfizer/BioNTech vaccine which includes excipient information.

Speaking to patients about any allergies, medical history and contraindications is necessary when seeking consent. Good record keeping is also essential in case problems arise during or after vaccination. Details of vaccinations - the vaccine type, dose, batch number, patient details and vaccinator - should be recorded using the recommended system. NHS England expects PCN vaccine services to use the Pinnacle point of care system, which will sync to the relevant GP record within 24 hours.

What should we do in the event of an error or adverse reaction to the vaccine?

If something goes wrong when administering the vaccine, tell the patient or their representative, apologise and explain the steps you will take to arrange appropriate treatment and follow-up. Follow duty of candour processes if you believe it to be a notifiable patient safety incident. If in doubt, contact your trust legal department or the MDU for further advice.

The MHRA has issued guidance to vaccination centres that any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer/BioNTech vaccine. Patients also need to be monitored for 15 minutes after vaccination, or longer if clinically indicated.

Short-term pain at the injection site and mild fever are common following the Pfizer/BioNTech vaccination but you should report suspected adverse reactions such as anaphylaxis to the MHRA using its dedicated coronavirus yellow card reporting site.

NHS England guidance sets out procedures for escalating COVID-19 vaccine incidents. It's important to include the vaccine brand and batch number to assist any investigation.

What about indemnity? Do I need to tell the MDU if I am administering the new vaccine?

We anticipate that for most members, including medical students, indemnity for clinical negligence claims will be provided under one of the state indemnity schemes (for example, CNSGP scheme in England).

For members with access to state indemnity, you only need to inform us if your hours or sessions have changed, or you are doing private COVID-19 vaccinations (if and when these become available). You don't need to tell us if you are vaccinating NHS patients within your usual hours or sessions.

Providers should have a documented agreement in place that makes clear that staff are acting on behalf of the provider.

A version of this article first appeared in GP online.

This page was correct at publication on 08/01/2021. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.

Dr Caroline Fryar

by Dr Caroline Fryar MBChB LLM MRCGP DCH DRCOG Head of medico-legal advisory services

Caroline studied medicine at the University of Sheffield then worked as a GP in Cheshire before joining the MDU in 2006. Whilst working at the MDU, Caroline obtained her LLM in Legal Aspects of Medical Practice and is currently studying for an MBA. 

You may also be interested in

FAQ

Can I refuse to treat a patient if there is inadequate PPE?

We know that our members are using their best efforts to try and resolve problems raised by the lack of availability of appropriate PPE pragmatically, but...

Read more
FAQ

I have a chronic health condition and am worried about developing COVID-19. What should I tell my employer?

Guidance from the Faculty of Occupational Health and the NHS Health at Work Network advises...

Read more
FAQ

Is there any guidance on discussing advance care plans with patients and their relatives during the COVID-19 outbreak?

The GMC and NMC published a joint statement on 15 April 2020 to guide those undertaking discussions about advance care planning...

Read more